Acute intermittent porphyria-another approach to therapy

1. 1. Acute Intermittent Porphyria patients in early or acute attacks were treated with folic acid (30 mg/day) administered orally for not longer than 10 days. 2. 2. Both clinical and biochemical improvement immediately followed folic acid administration. 3. 3. This is a simple and short-term therap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wider de Xifra, E.A., Batlle, A.M.d.C., Stella, A.M., Malamud, S.
Formato: JOUR
Materias:
aminolevulinic acid
folic acid
acute intermittent porphyria
blood and hemopoietic system
case report
drug therapy
drug urine level
porphyrin precursor
preliminary communication
therapy
urinary excretion
5-Aminolevulinate Synthetase
Acute Disease
Adult
Aminolevulinic Acid
Ammonia-Lyases
Case Report
Female
Folic Acid
Human
Male
Porphobilinogen
Porphobilinogen Synthase
Porphyria
Porphyrins
Support, Non-U.S. Gov't
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_0020711X_v12_n5-6_p819_WiderdeXifra
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires
Descripción
Sumario:1. 1. Acute Intermittent Porphyria patients in early or acute attacks were treated with folic acid (30 mg/day) administered orally for not longer than 10 days. 2. 2. Both clinical and biochemical improvement immediately followed folic acid administration. 3. 3. This is a simple and short-term therapy, which can be used either for treatment or prophylaxis. © 1980.

Ejemplares similares